The prevalence of Obstructive Sleep Apnea (OSA) in patients recovering from COVID-19

Schwarzl, G; Hayden, Markus; Limbach, Matthias; Schultz, Konrad

doi:10.1183/23120541.sleepandbreathing-2021.24

Cited by 2 publications

(4 citation statements)

References 0 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…This difference is most likely based on the definition of incapacity (partial vs. total). In the study by Davis et al,23.3% of patients were totally unable to work and 48% were partially unable to work, whereas in our study, the percentage of people partially unable to work was 62% [8,19]. In general, the inability to work usually lasts longer than 13 weeks [8,9,19].…”

Section: Cognitive Symptomscontrasting

confidence: 57%

“…Given such elevated ESS scores, obstructive sleep apnea syndrome (OSA) must be considered in the differential diagnostic workup for post-COVID-19 syndrome. In fact, a current study has shown a high rate of OSA in COVID-19-patients that exceeds the expected prevalence of OSA [23].…”

Section: Other Frequent Symptomscontrasting

confidence: 57%

“…Autonomic dysfunction, e.g., postural tachycardia syndrome (POTS), also occurs in post-COVID-19 syndrome. Depending on the literature, the frequency of tachycardia syndromes, including POTS, varies between 9 and 50% [10,[23][24][25]. The assessment of these autonomic symptoms, e.g., with the Schellong test, is particularly important, as symptoms such as postural tachycardia syndrome can be very limiting and can exacerbate fatigue.…”

Section: Other Frequent Symptomsmentioning

confidence: 99%

See 2 more Smart Citations

The Role of Neurorehabilitation in Post-COVID-19 Syndrome

Diem

Höfle

Fregolente

et al. 2023

CTN

View full text Add to dashboard Cite

Post-COVID-19 syndrome is an ongoing challenge for healthcare systems as well as for society. The clinical picture of post-COVID-19 syndrome is heterogeneous, including fatigue, sleep disturbances, pain, hair loss, and gastrointestinal symptoms such as chronic diarrhea. Neurological complaints such as fatigue, cognitive impairment, and sleep disturbances are common. Due to the short timeframe of experience and small amount of evidence in this field, the treatment of post-COVID-19 syndrome remains a challenge. Currently, therapeutic options for post-COVID-19 syndrome are limited to non-pharmaceutical interventions and the symptomatic therapy of respective symptoms. In this article, we summarize the current knowledge about therapeutic options for the treatment of neurological symptoms of post-COVID-19 syndrome.

show abstract

Section: Cognitive Symptomscontrasting

confidence: 57%

Section: Other Frequent Symptomscontrasting

confidence: 57%

Section: Other Frequent Symptomsmentioning

confidence: 99%

See 1 more Smart Citation

The Role of Neurorehabilitation in Post-COVID-19 Syndrome

Diem

Höfle

Fregolente

et al. 2023

CTN

View full text Add to dashboard Cite

show abstract

“…Coincidently, at the time of this publication, over a dozen studies have associated OSA with risk of COVID-19 [ 21 , 22 , 23 , 24 , 25 , 26 , 27 , 28 , 29 , 30 , 31 , 32 , 33 , 34 ], and many studies have associated COVID-19 with hypertension [ 35 , 36 , 37 , 38 , 39 , 40 , 41 , 42 , 43 , 44 , 45 , 46 , 47 , 48 ] and with preexisting and comorbid anxiety [ 49 , 50 , 51 , 52 , 53 , 54 , 55 ], although some findings of psychiatric disorders in COVID-19 are inconsistent [ 56 ]. Nevertheless, these relationships suggest that a common pathophysiological mechanism may mediate hypertension, anxiety, and OSA with increased risk for CVD and COVID-19.…”

Section: Introductionmentioning

confidence: 99%

Hypertension, Anxiety and Obstructive Sleep Apnea in Cardiovascular Disease and COVID-19: Mediation by Dietary Salt

Brown

2022

Diseases

View full text Add to dashboard Cite

This perspective paper used a grounded theory method to synthesize evidence proposing that sodium toxicity from excessive dietary salt intake is a potential common pathophysiological mechanism that mediates the association of hypertension, obstructive sleep apnea, and anxiety with cardiovascular disease and COVID-19. Increased anxiety in these conditions may be linked to a high-salt diet through stimulation of the sympathetic nervous system, which increases blood pressure while releasing catecholamines, causing a “fight or flight” response. A rostral shift of fluid overload from the lower to the upper body occurs in obstructive sleep apnea associated with COVID-19 and cardiovascular disease, and may be related to sodium and fluid retention triggered by hypertonic dehydration. Chronic activation of the renin-angiotensin-aldosterone system responds to salt-induced dehydration by increasing reabsorption of sodium and fluid, potentially exacerbating fluid overload. Anxiety may also be related to angiotensin II that stimulates the sympathetic nervous system to release catecholamines. More research is needed to investigate these proposed interrelated mechanisms mediated by dietary salt. Furthermore, dietary interventions should use a whole-food plant-based diet that eliminates foods processed with salt to test the effect of very low sodium intake levels on hypertension, anxiety, and obstructive sleep apnea in cardiovascular disease and COVID-19.

show abstract

The prevalence of Obstructive Sleep Apnea (OSA) in patients recovering from COVID-19

Cited by 2 publications

References 0 publications

The Role of Neurorehabilitation in Post-COVID-19 Syndrome

The Role of Neurorehabilitation in Post-COVID-19 Syndrome

Hypertension, Anxiety and Obstructive Sleep Apnea in Cardiovascular Disease and COVID-19: Mediation by Dietary Salt

Contact Info

Product

Resources

About